USSTOCK.TODAY
Market Closed
Log in Sign up

Gilead Sciences shares rise ahead of third-quarter earnings release

Earnings Whispers ·

GILD Gilead Sciences Inc
$157.19 +2.36%
View chart & analysis →
  1. 1Gilead Sciences Inc will announce its third-quarter results after the market closes on October 29.
  2. 2Analysts forecast third-quarter earnings per share of $2.16 and revenue of $7.81 billion for Gilead Sciences Inc.
  3. 3Gilead Sciences Inc raised its 2026 HIV growth outlook from 6% to 8%, and then to 9-10%.

So what's the key point?

Gilead Sciences is preparing to release its third-quarter financial results. With higher growth expectations in the HIV treatment sector, there is anticipation regarding the earnings experts are forecasting.

Source Earnings Whispers · View original ↗

Related 3-line summaries

Gilead shares up approximately 30% this year following consecutive FDA approvals The Motley Fool +1 · 4d agoGilead Sciences Signs 5-Year DevOps Extension Agreement with Cognizant Pharmaceutical Technology +1 · Oct 7Summit Therapeutics up 7.75% on positive Phase 3 ivosidenib data in cholangiocarcinoma InvestorsHub +1 · Aug 26
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →
← Back to news